av/bausch-health-companies--big.svg

NYSE:BHC

Bausch Health Companies Inc.

  • Stock

USD

Last Close

7.33

01/05 20:00

Market Cap

3.66B

Beta: 0.98

Volume Today

576.00K

Avg: 4.29M

PE Ratio

−2.93

PFCF: 2.98

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
916.78M
-
1.10B
20.38%
1.16B
5.00%
1.05B
9.00%
991M
6.02%
1.02B
2.98%
1.10B
7.84%
1.04B
5.18%
1.04B
0.19%
1.32B
26.45%
average payables
362.49M
-
415.85M
14.72%
378.85M
8.90%
344.50M
9.07%
388M
12.63%
457M
17.78%
420M
8.10%
372M
11.43%
464M
24.73%
620M
33.62%
average receivables
1.95B
-
2.38B
22.42%
2.60B
9.26%
2.32B
10.70%
2.00B
14.03%
1.85B
7.28%
1.71B
7.78%
1.68B
1.87%
1.78B
6.35%
1.89B
6.26%
book value per share
15.84
-
17.02
7.46%
9.08
46.68%
16.70
84.03%
7.81
53.23%
3.02
61.35%
1.51
50.08%
-0.30
119.60%
-1.91
545.63%
-2.80
46.88%
capex per share
-1.40
-
-0.87
37.76%
-0.84
4.06%
-0.96
14.51%
-0.67
29.99%
-0.79
17.55%
-0.87
10.24%
-0.79
9.41%
-0.74
6.34%
-0.75
0.94%
capex to depreciation
-0.27
-
-0.12
57.38%
-0.10
12.04%
-0.12
15.79%
-0.08
29.09%
-0.13
60.71%
-0.17
26.38%
-0.18
7.70%
-0.19
5.43%
-0.22
11.93%
capex to operating cash flow
-0.21
-
-0.14
32.79%
-0.14
1.16%
-0.15
5.23%
-0.16
6.70%
-0.19
18.30%
-0.28
50.17%
-0.20
28.65%
0.37
285.50%
-0.26
171.60%
capex to revenue
-0.06
-
-0.03
49.27%
-0.03
4.12%
-0.04
28.04%
-0.03
27.19%
-0.03
15.26%
-0.04
19.10%
-0.03
12.83%
-0.03
1.69%
-0.03
5.84%
cash per share
0.96
-
1.72
78.81%
1.56
9.26%
2.06
31.74%
2.06
0.23%
9.21
346.94%
1.70
81.50%
1.62
4.85%
1.55
4.16%
2.60
66.99%
days of inventory on hand
153.89
-
173.41
12.68%
148.32
14.47%
150.13
1.22%
145.01
3.41%
171.94
18.57%
177.55
3.26%
151.40
14.73%
168.30
11.16%
220.23
30.86%
days payables outstanding
64.43
-
59.85
7.11%
45.29
24.32%
52.29
15.44%
63.81
22.04%
78.13
22.44%
54.69
29.99%
62.05
13.46%
80.44
29.63%
102.55
27.49%
days sales outstanding
91.69
-
93.41
1.88%
94.97
1.66%
89.12
6.16%
81.23
8.85%
78.04
3.93%
71.71
8.11%
76.82
7.12%
80.42
4.69%
83.28
3.55%
debt to assets
0.58
-
0.64
9.69%
0.69
7.96%
0.68
1.05%
0.91
33.48%
0.76
15.57%
0.77
0.28%
0.78
1.16%
0.81
4.21%
0.82
1.25%
debt to equity
2.87
-
5.26
83.17%
9.47
79.98%
4.35
54.07%
9.10
109.10%
24.36
167.81%
44.72
83.58%
-213.72
577.90%
-30.01
85.96%
-21.91
27.00%
dividend yield
0.51
-
earnings yield
0.02
-
-0.01
139.65%
-0.48
6,245.06%
0.32
165.69%
-0.64
303.21%
-0.17
73.59%
-0.08
55.15%
-0.09
24.29%
-0.09
1.16%
-0.20
117.03%
enterprise value
62.80B
-
65.68B
4.58%
34.33B
47.74%
32.35B
5.77%
30.38B
6.07%
33.18B
9.22%
30.68B
7.54%
32.00B
4.30%
22.47B
29.77%
24.37B
8.41%
enterprise value over ebitda
15.20
-
12.92
15.00%
6.29
51.31%
9.49
50.92%
9.57
0.83%
18.19
90.06%
12.19
33.02%
12.38
1.59%
8.69
29.77%
8.43
3.00%
ev to operating cash flow
27.37
-
29.85
9.06%
16.45
44.90%
14.12
14.13%
20.24
43.31%
22.11
9.22%
27.62
24.92%
22.44
18.74%
-30.87
237.57%
23.61
176.48%
ev to sales
7.60
-
6.26
17.68%
3.55
43.28%
3.71
4.49%
3.63
2.21%
3.86
6.42%
3.82
0.93%
3.79
0.74%
2.77
27.09%
2.78
0.58%
free cash flow per share
5.44
-
5.46
0.44%
5.17
5.33%
5.58
7.90%
3.62
35.15%
3.47
4.01%
2.26
34.96%
3.18
40.97%
-2.74
186.18%
2.08
175.89%
free cash flow yield
0.04
-
0.05
41.52%
0.36
563.78%
0.26
28.38%
0.20
23.70%
0.12
40.64%
0.11
6.18%
0.12
5.68%
-0.44
480.67%
0.26
159.31%
graham net net
-55.35
-
-114.29
106.50%
-107.43
6.00%
-81.99
23.68%
-63.01
23.15%
-78.25
24.18%
-79.60
1.73%
-74.75
6.10%
-63.31
15.30%
-66.36
4.82%
graham number
31.15
-
17.13
45.01%
37.64
119.67%
50.79
34.95%
45.65
10.12%
18.55
59.37%
7.31
60.60%
4.17
43.00%
5.01
20.19%
10.11
101.97%
income quality
2.52
-
-7.65
403.93%
-0.87
88.66%
0.95
209.91%
-0.36
138.02%
-0.84
132.42%
-1.99
136.09%
-1.52
23.43%
3.43
325.64%
-1.69
149.19%
intangibles to total assets
0.78
-
0.85
8.77%
0.80
6.31%
0.82
3.12%
0.92
11.51%
0.69
24.80%
0.69
0.01%
0.66
3.52%
0.68
1.63%
0.64
4.50%
interest coverage
2.10
-
0.99
52.66%
-0.31
131.00%
0.06
117.98%
-1.41
2,652.25%
-0.05
96.80%
0.44
1,073.11%
0.85
92.55%
0.94
10.28%
0.73
22.51%
interest debt per share
48.40
-
94.06
94.36%
91.24
3.00%
77.91
14.61%
75.87
2.62%
78.12
2.97%
71.72
8.20%
67.09
6.44%
61.26
8.70%
64.99
6.10%
inventory turnover
2.37
-
2.10
11.25%
2.46
16.91%
2.43
1.20%
2.52
3.53%
2.12
15.66%
2.06
3.16%
2.41
17.27%
2.17
10.04%
1.66
23.58%
invested capital
2.87
-
5.26
83.17%
9.47
79.98%
4.35
54.07%
9.10
109.10%
24.36
167.81%
44.72
83.58%
-213.72
577.90%
-30.01
85.96%
-21.91
27.00%
market cap
47.87B
-
35.18B
26.51%
5.02B
85.74%
7.62B
51.92%
6.47B
15.09%
10.53B
62.75%
7.36B
30.10%
9.93B
34.86%
2.27B
77.11%
2.92B
28.67%
net current asset value
-16.73B
-
-37.43B
123.78%
-35.19B
5.97%
-26.81B
23.83%
-23.91B
10.81%
-25.76B
7.73%
-25.25B
1.96%
-23.63B
6.43%
-21.18B
10.37%
-21.84B
3.10%
net debt to ebitda
3.61
-
6.00
65.99%
5.37
10.48%
7.26
35.11%
7.53
3.81%
12.42
64.85%
9.26
25.43%
8.54
7.80%
7.82
8.47%
7.42
5.03%
net income per share
2.72
-
-0.77
128.14%
-6.94
804.96%
6.86
198.97%
-11.86
272.71%
-5.06
57.29%
-1.57
68.90%
-2.61
65.80%
-0.58
77.62%
-1.62
177.72%
operating cash flow per share
6.84
-
6.34
7.40%
6.01
5.15%
6.54
8.82%
4.29
34.39%
4.26
0.63%
3.13
26.59%
3.97
26.96%
-2.01
150.49%
2.83
240.98%
payables turnover
5.66
-
6.10
7.66%
8.06
32.14%
6.98
13.37%
5.72
18.06%
4.67
18.33%
6.67
42.84%
5.88
11.86%
4.54
22.86%
3.56
21.56%
receivables turnover
3.98
-
3.91
1.85%
3.84
1.64%
4.10
6.56%
4.49
9.71%
4.68
4.09%
5.09
8.83%
4.75
6.65%
4.54
4.48%
4.38
3.43%
research and ddevelopement to revenue
0.03
-
0.06
86.47%
0.05
15.27%
0.04
10.80%
0.05
17.76%
0.05
10.84%
0.06
2.83%
0.06
2.09%
0.07
18.10%
0.07
5.92%
return on tangible assets
0.16
-
-0.04
122.87%
-0.27
649.31%
0.36
231.97%
-1.80
601.24%
-0.17
90.60%
-0.06
65.98%
-0.10
66.13%
-0.03
73.42%
-0.06
139.79%
revenue per share
24.64
-
30.23
22.70%
27.85
7.86%
24.91
10.57%
23.95
3.85%
24.43
1.99%
22.61
7.44%
23.50
3.93%
22.39
4.74%
24.00
7.20%
roe
0.17
-
-0.05
126.19%
-0.76
1,597.08%
0.41
153.78%
-1.52
469.27%
-1.68
10.51%
-1.04
37.71%
8.84
946.01%
0.31
96.53%
0.58
89.08%
roic
0.08
-
0.09
3.89%
-0.02
119.72%
-0.00
73.46%
-0.09
1,815.01%
-0.00
96.95%
0.02
729.33%
0.05
196.87%
0.11
128.41%
0.07
37.04%
sales general and administrative to revenue
shareholders equity per share
15.84
-
17.02
7.46%
9.08
46.68%
16.70
84.03%
7.81
53.23%
3.02
61.35%
1.51
50.08%
-0.30
119.60%
-1.91
545.63%
-2.80
46.88%
stock based compensation to revenue
0.01
-
0.01
41.01%
0.02
27.81%
0.01
41.53%
0.01
4.11%
0.01
14.23%
0.01
10.30%
0.02
16.02%
0.02
2.19%
0.02
2.81%
tangible asset value
-15.17B
-
-35.61B
134.75%
-31.42B
11.76%
-24.86B
20.88%
-22.33B
10.19%
-22.19B
0.61%
-20.88B
5.89%
-19.44B
6.92%
-17.09B
12.10%
-17.72B
3.71%
tangible book value per share
-45.22
-
-102.52
126.70%
-90.47
11.76%
-70.99
21.53%
-63.82
10.10%
-63.02
1.24%
-58.83
6.66%
-54.16
7.93%
-47.08
13.07%
-48.56
3.14%
working capital
1.46B
-
194.60M
86.69%
1.47B
654.37%
478M
67.44%
-3.11B
751.26%
721M
123.16%
429M
40.50%
409M
4.66%
306M
25.18%
1.29B
322.88%

All numbers in USD (except ratios and percentages)